About This Study
The purpose of this study is to learn more about the medicine ADU-1805 when given with the cancer medicine pembrolizumab (Keytruda). We want to see if it is safe and can help treat advanced solid tumors. We will also look at how the body responds to and processed the study treatment. This study is for volunteers diagnosed with an advanced solid tumor, such as colorectal cancer, endometrial cancer, kidney cancer, or non-small cell lung cancer.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- Use of Study Health Plans
- Review of Medical History
- Physical Examinations
- Study Visits and Consultations
- Laboratory and Imaging Tests
- Specimen Sample Collection
Age & Gender
- 18 - 100+ years old
- Female
- Male
Language
- This study enrolls English and Spanish speakers
Additional Study Information
- No compensation provided
- Reimbursement offered
Study Locations
- Greater Charlotte, NC
- Greater Winston-Salem, NC